Old Web
English
Sign In
Acemap
>
authorDetail
>
Leslie M. Randall
Leslie M. Randall
University of California, Berkeley
Medicine
Ovarian cancer
Internal medicine
Adenocarcinoma
Adverse effect
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer.
2021
Journal of Clinical Oncology
Janos L. Tanyi
Hye Sook Chon
Mark A. Morgan
Setsuko K. Chambers
Ernest S. Han
Kristina A. Butler
Carrie L. Langstraat
Matthew A. Powell
Leslie M. Randall
Alexander L. Vahrmeijer
Ira Winer
Robert M. Wenham
Show All
Source
Cite
Save
Citations (2)
Uplift (ENGOT-ov67): A pivotal cohort to evaluate XMT-1536 (upifitamab rilsodotin), a NaPi2b-directed antibody drug conjugate for platinum-resistant ovarian cancer.
2021
Journal of Clinical Oncology
Debra L. Richardson
Erika Hamilton
Ana Oaknin
Leslie M. Randall
Susana Banerjee
Sara K. Taylor
Linda Mileshkin
Robert L. Coleman
Bradley J. Monk
Mansoor Raza Mirza
Patricia Bernardo
Rebecca Mosher
Valerie M. Jansen
Antonella Savarese
Toon Van Gorp
Radosław Mądry
Isabelle Ray-Coquard
Nicole Concin
Show All
Source
Cite
Save
Citations (0)
1